Delays in treatment are shown to significantly impact patient outcomes and indicate that improved Lyme disease diagnosis and prevention strategies are needed.
Treatment Delays Increase Risk of Persistent Illness in Lyme Disease
Lyme Disease Research Highlights
Metabolic Response in Patients with Post-Treatment Lyme Disease
Objective metabolite-based measurements differ between Lyme disease patients that develop persistent symptoms following antibiotic treatment (PTLD) and those that are clinically cured. These differences could be useful in better identifying, differentiating, and understanding the underlying biochemistry of patients with persistent symptoms in Lyme disease.
Lyme disease bacteria induce changes in self-immunopeptides expressed by dendritic cells
Lyme disease infection and genetic susceptibility to autoimmune diseases may trigger breakdown in tolerance to self-antigens & contribute to dysregulated immunity, autoimmune illness, & persistent symptoms
Distinct Gut Microbiome Signature in Lyme Disease Patients
This distinct PTLD microbiome signature presents a potential novel objective Lyme disease diagnostic tool and new avenue for therapeutics.
An artificial intelligence and deep learning-based approach can improve the early detection of the Lyme disease rash
Summary This study shows that artificial intelligence (AI) and deep learning (DL) methods can be used to analyze cell phone rash images to more accurately detect and prescreen the erythema […]
Post-Treatment Lyme Disease as a Research Model for Persistent Symptoms in Lyme Disease
Summary The aim of this paper is to review the current literature on the diagnosis, etiology, risk factors, treatments and heterogeneity of patients with persistent symptoms of Lyme disease. The […]
